Chair: Prof. Simon Benita, PhD, Head of Nano Delivery Systems, Hebrew University of Jerusalem
Session 1: Nanomedicine: Future Promises
12:00-12:30 Anand Subramony, PhD, Vice President, Novel Product Technologies, MedImmune: “Nanomedicine and its Role in New Medical Therapeutics”
12:30-13:00 Prof. Dina Ben-Yehuda, PhD, Dean, Hadassah-Hebrew University Faculty of Medicine “Targeted Nanoparticles for Improved Hematological Cancers”
Session 2: Presentation of Start-ups
13:00-13:15 Alon Moran, CEO, BioNanoSim Ltd: “Innovative Nano-carriers for Improved Delivery and Drug Performance”
13-15-13:30 Amotz Shemi, PhD, CEO, Silenseed Ltd: “RNA Interference is Progressing Toward Commercialization – the Case of Phase 2 in Pancreatic Cancer”
13:30-13:45 Yoram Ashery, CEO, Nobio Ltd: “Nobio Nanoparticles for Permanent Antimicrobial Protection”
13:45-14:00 Ronen Eavri, PhD, CEO, Barcode Diagnostics: “Barcoded Nanoparticles for Personalized Drug Screening in Cancer Patients”
14:00-15:30 Lunch Break
15:30-15:45 Amir Bahar, PhD, CEO, Nurami Ltd: “Scaffolds of Electrospun Nanofibers for Soft Tissue Repair”
15:45-16:00 Shlomzion Shen, PhD, MBA, CEO, Seevix Material Sciences Ltd: “Seevix Spidersilk “SVXgro”: First Man-Made Spidersilk Produced With Bio- and Nano-Technology”
Session 3: Nanotechnology Up-scaling Challenges: From Bench to the Market
16:00-16:07 Menashe Levy, PhD, CTO, Clexio Biosciences: “Regulatory and CMC Considerations of Nanotechnology Pharma applications”
16:07-16:15 Shimon Amselem, PhD, Chief Scientist, Delivery Technologies, Adama Ltd: “Challenges in the Development and Up-scaling of Liposomes for Diagnostic Imaging”
16:15-16:30 Frederic Lallemand, PhD, Scientist, Santen SAS, “Challenges in the Up-scaling Manufacturing of Cationic Nanoemulsions“
16:30-16:45 Prof. Simon Benita, PhD, Head of Nano Delivery Systems, Hebrew University of Jerusalem: “Challenges in the Development and Up-scaling of Drug-loaded Nanoparticles”
Session 4 Closing Lecture
16:45-17:15 Prof. Ronit Satchi-Fainaro, PhD, Head, Cancer Angiogenesis & Nanomedicine Laboratory, Sackler Faculty of Medicine, Tel Aviv University: “Reverting Cancer’s Poor Prognosis using Precision Nanomedicines Based on Molecular Fingerprints of Long-term vs Short-term Survivors“
